CVS Health (NYSE:CVS) Shares Up 1%

Shares of CVS Health Co. (NYSE:CVSGet Free Report) were up 1% on Friday . The stock traded as high as $56.85 and last traded at $56.18. Approximately 3,989,144 shares traded hands during mid-day trading, a decline of 67% from the average daily volume of 11,926,769 shares. The stock had previously closed at $55.65.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. StockNews.com downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a report on Wednesday, May 1st. Cantor Fitzgerald cut shares of CVS Health from an “overweight” rating to a “neutral” rating and reduced their target price for the company from $87.00 to $58.00 in a report on Wednesday, May 1st. Argus dropped their price target on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Finally, Mizuho cut their price target on CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Nine research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $76.75.

Check Out Our Latest Analysis on CVS

CVS Health Stock Performance

The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78. The stock has a market capitalization of $69.72 billion, a PE ratio of 9.76, a PEG ratio of 0.53 and a beta of 0.56. The business’s 50 day moving average is $67.13 and its 200 day moving average is $71.92.

CVS Health (NYSE:CVSGet Free Report) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same quarter in the previous year, the company posted $2.20 earnings per share. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, equities research analysts predict that CVS Health Co. will post 7.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were given a $0.665 dividend. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.79%. CVS Health’s dividend payout ratio (DPR) is 46.75%.

Insider Transactions at CVS Health

In other news, Director Edward J. Ludwig purchased 1,000 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was purchased at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the acquisition, the director now owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.24% of the company’s stock.

Institutional Investors Weigh In On CVS Health

Several hedge funds have recently made changes to their positions in the company. SOA Wealth Advisors LLC. grew its holdings in CVS Health by 4.9% during the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock worth $226,000 after acquiring an additional 133 shares in the last quarter. Apella Capital LLC raised its stake in shares of CVS Health by 4.2% during the 4th quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock worth $272,000 after acquiring an additional 136 shares in the last quarter. Prairie Sky Financial Group LLC boosted its stake in CVS Health by 4.1% in the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after acquiring an additional 141 shares in the last quarter. WealthShield Partners LLC lifted its holdings in shares of CVS Health by 3.2% during the 4th quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after purchasing an additional 141 shares during the last quarter. Finally, Sugarloaf Wealth Management LLC grew its stake in CVS Health by 9.5% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock worth $129,000 after buying an additional 142 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Company Profile

(Get Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Featured Articles

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.